Skip to main content

Intersect ENT, Inc.

XENTDelisted May 13, 2022
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001271214

Intersect ENT, Inc. was delisted on May 13, 2022; its insiders filed their last Form 4 on May 16, 2022; 131 institutions reported holding it in 13F filings for Q1 2022, worth $828.8M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Intersect ENT, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of XENT: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders1241121−2
Shares29.7M456.4K30.5M+1.23M (+4.2%)
Value$806.7M$12.4M$831.7M+$37.3M (+4.7%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (20)

Institutions that held Intersect ENT, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to XENT in Q4 2021
InstitutionSharesValue% of portfolio
Kite Lake Capital Management (UK) LLP1,320,000$36.0M9.74%
Melqart Asset Management (UK) Ltd615,000$16.8M0.95%
Omni Event Management Ltd441,838$12.1M0.68%
Natixis366,200$10.0M0.03%
Calamos Advisors LLC202,386$5.53M0.02%
Candriam Luxembourg S.C.A.199,744$5.46M0.03%
Glazer Capital, LLC144,918$3.96M0.10%
Yakira Capital Management, Inc.67,132$1.83M0.23%
Marshall Wace, LLP65,558$1.79M0.00%
Pentwater Capital Management LP25,000$683.0K0.01%
Sarissa Consulting LLC23,097$631.0K0.81%
Walleye Capital LLC22,008$601.0K0.02%
BTG Pactual Global Asset Management Ltd11,759$321.0K0.33%
Engineers Gate Manager LP9,240$252.0K0.01%
Diametric Capital, LP8,506$232.0K0.18%
Sagefield Capital LP6,709$183.0K0.08%
Water Island Capital LLC3,886$106.0K0.01%
FMR LLC67$2.00K0.00%
Quadrant Capital Group LLC55$2.00K0.00%
Delos Wealth Advisors, LLC22$1.00K0.00%

Sold out (22)

Institutions that held Intersect ENT, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Not filed for Q4 2021 yet (1)

Institutions that held Intersect ENT, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding XENT in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Omni Partners US LLC456,396$12.4M